Optimizing management of chronic obstructive pulmonary disease in the upcoming decade

References

• Global Initiative for Chronic Obstructive Lung DiseaseGlobal strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease Updated 2009. Available from: www.goldcopd.comAccessed 2010 May 12
   Google Scholar
• BuistASVollmerWMMcBurnieMAWorldwide burden of COPD in high- and low-income countries. Part I. The burden of obstructive lung disease (BOLD) initiativeInt J Tuberc Lung Dis20081270370818544191
   PubMed Web of Science ®Google Scholar
• ManninoDMBuistASGlobal burden of COPD: Risk factors, prevalence, and future trendsLancet200737076577317765526
   PubMed Web of Science ®Google Scholar
• MathersCDLoncarDProjections of global mortality and burden of disease from 2002 to 2030PLoS Med20063e44217132052
   PubMed Web of Science ®Google Scholar
• SullivanSDRamseySDLeeTAThe economic burden of COPDChest2000117S59
   Web of Science ®Google Scholar
• ShavelleRMPaculdoDRKushSJManninoDMStraussDJLife expectancy and years of life lost in chronic obstructive pulmonary disease: Findings from the NHANES III Follow-up StudyInt J Chron Obstruct Pulmon Dis2009413714819436692
   PubMedGoogle Scholar
• HoggJCPathophysiology of airflow limitation in chronic obstructive pulmonary diseaseLancet200436470972115325838
   PubMed Web of Science ®Google Scholar
• CooperCBDransfieldMPrimary care of the patient with chronic obstructive pulmonary disease – Part 4: Understanding the clinical manifestations of a progressive diseaseAm J Med20081217 SupplS334518558106
   PubMed Web of Science ®Google Scholar
• WoutersEFEconomic analysis of the Confronting COPD survey: An overview of resultsRespir Med200397Suppl CS31412647938
   PubMed Web of Science ®Google Scholar
• ChatilaWMThomashowBMMinaiOACrinerGJMakeBJComorbidities in chronic obstructive pulmonary diseaseProc Am Thorac Soc2008554955518453370
   PubMedGoogle Scholar
• LindbergAJonssonACRonmarkELundgrenRLarssonLGLundbäckBPrevalence of chronic obstructive pulmonary disease according to BTS, ERS, GOLD and ATS criteria in relation to doctor’s diagnosis, symptoms, age, gender, and smoking habitsRespiration20057247147916210885
   PubMed Web of Science ®Google Scholar
• British Lung FoundationInvisible livesChronic obstructive lung disease (COPD) – finding the missing millions Available from: http://www.lunguk.orgAccessed 2010 May 12
   Google Scholar
• KohansalRMartinez-CamblorPAgustiABuistASManninoDMSorianoJBThe natural history of chronic airflow obstruction revisited: An analysis of the Framingham offspring cohortAm J Respir Crit Care Med200918031019342411
   PubMed Web of Science ®Google Scholar
• CelliBRMacNeeWATS/ERS Task ForceStandards for the diagnosis and treatment of patients with COPD: A summary of the ATS/ERS position paperEur Respir J20042393294615219010
   PubMed Web of Science ®Google Scholar
• O’DonnellDEAaronSBourbeauJCanadian Thoracic Society recommendations for management of chronic obstructive pulmonary disease – 2007 updateCan Respir J200714Suppl BB532
   PubMed Web of Science ®Google Scholar
• HalpinDNICE guidance for COPDThorax20045918118214985544
   PubMed Web of Science ®Google Scholar
• FletcherCPetoRThe natural history of chronic airflow obstructionBr Med J1977116451648871704
   PubMed Web of Science ®Google Scholar
• DecramerMCelliBKestenSLystigTMehraSTashkinDPUPLIFT investigatorsEffect of tiotropium on outcomes in patients with moderate chronic obstructive pulmonary disease (UPLIFT): A prespecified subgroup analysis of a randomised controlled trialLancet20093741171117819716598
   PubMed Web of Science ®Google Scholar
• JenkinsCRJonesPWCalverleyPMEfficacy of salmeterol/fluticasone propionate by GOLD stage of chronic obstructive pulmonary disease: Analysis from the randomised, placebo-controlled TORCH studyRespir Res2009105919566934
   PubMed Web of Science ®Google Scholar
• ManninoDMWattGHoleDThe natural history of chronic obstructive pulmonary diseaseEur Respir J20062762764316507865
   PubMed Web of Science ®Google Scholar
• TashkinDPFrequent exacerbations of chronic obstructive pulmonary disease – a distinct phenotypeNew Engl J Med20103631183118420843256
   PubMed Web of Science ®Google Scholar
• HurstJRVestboJAnzuetoASusceptibility to exacerbation in chronic obstructive pulmonary diseaseNew Engl J Med20103631128113820843247
   PubMed Web of Science ®Google Scholar
• BridevauxPOGerbaseMWProbst-HenschNMSchindlerCGaspozJMRochatTLong-term decline in lung function, utilisation of care and quality of life in modified GOLD stage 1 COPDThorax20086376877418505800
   PubMed Web of Science ®Google Scholar
• OfirDLavenezianaPWebbKALamYMO’DonnellDEMechanisms of dyspnea during cycle exercise in symptomatic patients with GOLD stage I chronic obstructive pulmonary diseaseAm J Respir Crit Care Med200817762262918006885
   PubMed Web of Science ®Google Scholar
• TroostersTSciurbaFBattagliaSPhysical inactivity in patients with COPD, a controlled multi-center pilot-studyRespir Med20101041005101120167463
   PubMed Web of Science ®Google Scholar
• Garcia-AymerichJSerraIGómezFPPhysical activity and clinical and functional status in COPDChest2009136627019255291
   PubMed Web of Science ®Google Scholar
• DonaldsonGCSeemungalTARBhowmikAWedzichaJARelationship between exacerbation frequency and lung function decline in chronic obstructive pulmonary diseaseThorax20025784785212324669
   PubMed Web of Science ®Google Scholar
• MakrisDMoschandreasJDamianakiAExacerbations and lung function decline in COPD: New insights in current and ex-smokersRespir Med20071011305131217112715
   PubMed Web of Science ®Google Scholar
• PaggiaroPLDahleRBakranIMulticentre randomised placebocontrolled trial of inhaled fluticasone propionate in patients with chronic obstructive pulmonary disease. International COPD Study GroupLancet19983517737809519948
   PubMed Web of Science ®Google Scholar
• GompertzSBayleyDLHillSLStockleyRARelationship between airway inflammation and the frequency of exacerbations in patients with smoking related COPDThorax200156364111120902
   PubMed Web of Science ®Google Scholar
• PereraWRHurstJRWilkinsonTMInflammatory changes, recovery and recurrence at COPD exacerbationEur Respir J20072952753417107990
   PubMed Web of Science ®Google Scholar
• PittaFTroostersTProbstVSSpruitMADecramerMGosselinkRPhysical activity and hospitalization for exacerbation of COPDChest200612953654416537849
   PubMed Web of Science ®Google Scholar
• HurstJRDonaldsonGCQuintJKGoldringJJBaghai-RavaryRWedzichaJATemporal clustering of exacerbations in chronic obstructive pulmonary diseaseAm J Respir Crit Care Med200917936937419074596
   PubMed Web of Science ®Google Scholar
• TsaiCLRoweBHCamargoCAJrFactors associated with short-term recovery of health status among emergency department patients with acute exacerbations of chronic obstructive pulmonary diseaseQual Life Res20091819119919123070
   PubMed Web of Science ®Google Scholar
• GroenewegenKHDentenerMAWoutersEFLongitudinal follow-up of systemic inflammation after acute exacerbations of COPDRespir Med20071012409241517644367
   PubMed Web of Science ®Google Scholar
• GlaabTBanikNRutschmannOTWenckerMNational survey of guideline-compliant COPD management among pneumologists and primary care physiciansCOPD2006314114817240616
   PubMedGoogle Scholar
• RutschmannOTJanssensJPVermeulenBSarasinFPKnowledge of guidelines for the management of COPD: A survey of primary care physiciansRespir Med20049893293715481268
   PubMed Web of Science ®Google Scholar
• TaMGeorgeJManagement of COPD in Australia after the publication of national guidelinesIntern Med J
   Google Scholar
• DeromEvan WeelCLiistroGPrimary care spirometryEur Respir J20083119720318166597
   PubMed Web of Science ®Google Scholar
• LusuardiMDe BenedettoFPaggiaroPA randomized controlled trial on off ice spirometry in asthma and COPD in standard general practice: Data from spirometry in asthma and COPD: A comparative evaluation Italian studyChest200612984485216608929
   PubMed Web of Science ®Google Scholar
• ArneMLisspersKStällbergBBomanGHow often is diagnosis of COPD confirmed with spirometryRespir Med201010455055619931443
   PubMed Web of Science ®Google Scholar
• JonesRCDickson-SpillmannMMatherMJMarksDShackellBSAccuracy of diagnostic registers and management of chronic obstructive pulmonary disease: The Devon primary care auditRespir Res200896218710575
   PubMed Web of Science ®Google Scholar
• DonohueJFvan NoordJABatemanEDA 6-month, placebocontrolled study comparing lung function and health status changes in COPD patients treated with tiotropium or salmeterolChest2002122475512114338
   PubMed Web of Science ®Google Scholar
• BrusascoVHodderRMiravitllesMKorduckiLTowseLKestenSHealth outcomes following treatment for six months with once daily tiotropium compared with twice daily salmeterol in patients with COPDThorax2006619116396956
   PubMed Web of Science ®Google Scholar
• VogelmeierCKardosPHarariSGansSJStengleinSThirlwellJFormoterol mono- and combination therapy with tiotropium in patients with COPD: A 6-month studyRespir Med20081021511152018804362
   PubMed Web of Science ®Google Scholar
• van NoordJAAumannJLJanssensEComparison of tiotropium once daily, formoterol twice daily and both combined once daily in patients with COPDEur Respir J20052621422216055868
   PubMed Web of Science ®Google Scholar
• VinckenWBronchodilator treatment of stable COPD: Long-acting anticholinergicsEur Respir Rev2005142331
   Google Scholar
• WelteTMiravitllesMHernandezPEfficacy and tolerability of budesonide/formoterol added to tiotropium in patients with chronic obstructive pulmonary diseaseAm J Respir Crit Care Med200918074175019644045
   PubMed Web of Science ®Google Scholar
• CazzolaMDahlRInhaled combination therapy with longacting beta 2-agonists and corticosteroids in stable COPDChest200412622023715249466
   PubMed Web of Science ®Google Scholar
• CalverleyPMAndersonJACelliBTORCH investigatorsSalmeterol and fluticasone propionate and survival in chronic obstructive pulmonary diseaseN Engl J Med200735677578917314337
   PubMed Web of Science ®Google Scholar
• WedzichaJACalverleyPMSeemungalTAHaganGAnsariZStockleyRAINSPIRE InvestigatorsThe prevention of chronic obstructive pulmonary disease exacerbations by salmeterol/fluticasone propionate or tiotropium bromideAm J Respir Crit Care Med2008177192617916806
   PubMed Web of Science ®Google Scholar
• SinghDBrooksJHaganGCahnAO’ConnorBJSuperiority of “triple” therapy with salmeterol/fluticasone propionate and tiotropium bromide versus individual components in moderate to severe COPDThorax20086359259818245142
   PubMed Web of Science ®Google Scholar
• PerngDWWuCCSuKCLeeYCPerngRPTaoCWAdditive benefits of tiotropium in COPD patients treated with long-acting beta agonists and corticosteroidsRespirology20061159860216916333
   PubMed Web of Science ®Google Scholar
• CosioBGIglesiasARiosALow-dose theophylline enhances the anti-inflammatory effects of steroids during exacerbations of COPDThorax20096442442919158122
   PubMed Web of Science ®Google Scholar
• PoolePJBlackPNMucolytic agents for chronic bronchitis or chronic obstructive pulmonary diseaseCochrane Database Syst Rev20033CD001287
   Google Scholar
• SteyCSteurerJBachmannSMediciTCTramèrMRThe effect of oral N-acetylcysteine in chronic bronchitis: A quantitative systematic reviewEur Respir J20001625326210968500
   PubMed Web of Science ®Google Scholar
• ZhengJPKangJHuangSGEffect of carbocisteine on acute exacerbation of chronic obstructive pulmonary disease (PEACE Study): A randomised placebo-controlled studyLancet20083712013201818555912
   PubMed Web of Science ®Google Scholar
• DecramerMRutten-van MölkenMDekhuijzenPNEffects of N-acetylcysteine on outcomes in chronic obstructive pulmonary disease (Bronchitis Randomized on NAC Cost-Utility Study, BRONCUS): A randomised placebo-controlled trialLancet20053651552156015866309
   PubMed Web of Science ®Google Scholar
• VestboJAndersonJACalverleyPMAdherence to inhaled therapy, mortality and hospital admission in COPDThorax20096493994319703830
   PubMed Web of Science ®Google Scholar
• BatemanEDImproving inhaler use in COPD and the role of patient preferenceEur Respir Rev2005148588
   Google Scholar
• LaghiFAdiguzelNTobinMJEndocrinological derangements in COPDEur Respir J20093497599619797671
   PubMed Web of Science ®Google Scholar
• DecramerMRennardSTroostersTCOPD as a lung disease with systemic consequences – clinical impact, mechanisms, and potential for early interventionCOPD2008523525618671149
   PubMedGoogle Scholar
• DonohueJFFogartyCLötvallJINHANCE study investigatorsOnce-daily bronchodilators for chronic obstructive pulmonary disease: Indacaterol versus tiotropiumAm J Respir Crit Care Med201018215516220463178
   PubMed Web of Science ®Google Scholar
• DahlRChungKFBuhlRINVOLVE (INdacaterol: Value in COPD: Longer Term Validation of Efficacy and Safety) Study InvestigatorsEfficacy of a new once-daily long-acting inhaled beta2- agonist indacaterol versus twice-daily formoterol in COPDThorax20106547347920522841
   PubMed Web of Science ®Google Scholar
• SotoFJHananiaNASelective phosphodiesterase-4 inhibitors in chronic obstructive lung diseaseCurr Opin Pulm Med20051112913415699784
   PubMed Web of Science ®Google Scholar
• CalverleyPMRabeKFGoehringUMKristiansenSFabbriLMMartinezFJM2–124 and M2–125 study groups. Roflumilast in symptomatic chronic obstructive pulmonary disease: Two randomised clinical trialsLancet200937468569419716960
   PubMed Web of Science ®Google Scholar
• RabeKFBatemanEDO’DonnellDWitteSBredenbrökerDBethkeTDRoflumilast – an oral anti-inflammatory treatment for chronic obstructive pulmonary disease: A randomised controlled trialLancet200536656357116099292
   PubMed Web of Science ®Google Scholar
• FabbriLMCalverleyPMIzquierdo-AlonsoJLBroseMMartinezFJRabeKFM2-127 and M2-128 study groups. Roflumilast in moderate-to- severe chronic obstructive pulmonary disease treated with longacting bronchodilators: Two randomised clinical trialsLancet200937469570319716961
   PubMed Web of Science ®Google Scholar
• European Medicines Agency and Committee for Medicinal Products for Human UseSummary of opinion (initial authorisation)Daxas. Roflumilast Available from: http://www.ema.europa.euAccessed 2010 May 12
   Google Scholar
• ChanezPAclidinium bromide provides long-acting bronchodilation in patients with COPDPulm Pharmacol Ther201023152119683590
   PubMed Web of Science ®Google Scholar
• AnzuetoATashkinDMenjogeSKestenSOne-year analysis of longitudinal changes in spirometry in patients with COPD receiving tiotropiumPulm Pharmacol Ther200518758115649848
   PubMed Web of Science ®Google Scholar
• TashkinDPCelliBSennSUPLIFT® Study InvestigatorsA 4-year trial of tiotropium in chronic obstructive pulmonary diseaseN Engl J Med20083591543155418836213
   PubMed Web of Science ®Google Scholar
• CelliBRThomasNEAndersonJAEffect of pharmacotherapy on rate of decline of lung function in chronic obstructive pulmonary disease: Results from the TORCH studyAm J Respir Crit Care Med200817833233818511702
   PubMed Web of Science ®Google Scholar
• HananiaNKestenSCelliBAcute bronchodilator response does not predict health outcomes in patients with COPD treated with tiotropiumEur Respir J200934Suppl 53S777
   Google Scholar
• AnthonisenNRConnettJEKileyJPEffects of smoking intervention and the use of an inhaled anticholinergic bronchodilator on the rate of decline of FEV1. The Lung Health StudyJAMA1994272149715057966841
   PubMed Web of Science ®Google Scholar
• Long term domiciliary oxygen therapy in chronic hypoxic cor pulmonale complicating chronic bronchitis and emphysema Report of the Medical Research Council Working PartyLancet198116816866110912
   PubMed Web of Science ®Google Scholar
• MoriceAHCelliBKestenSLystigTTashkinDDecramerMCOPD in young patients: A pre-specified analysis of the four-year trial of tiotropium (UPLIFT)Respir Med20101041659166720724131
   PubMed Web of Science ®Google Scholar
• TroostersTCelliBLystigTTiotropium as a first maintenance drug in COPD: Secondary analysis of the UPLIFT® trialEur Respir J201036657320185426
   PubMed Web of Science ®Google Scholar
• JonesPHardingGWiklundIBerryPLeidyNImproving the process and outcome of care in COPD: Development of a standardised assessment toolPrim Care Respir J20091820821519690787
   PubMedGoogle Scholar
• MartinezFJRaczekAESeiferFDDevelopment and initial validation of a self-scored COPD Population Screener Questionnaire (COPD-PS)COPD20085859518415807
   PubMedGoogle Scholar
• de MarcoRAccordiniSCerveriICorsicoASunyerJNeukirchFAn international survey of chronic obstructive pulmonary disease in young adults according to GOLD stagesThorax20045912012514760151
   PubMed Web of Science ®Google Scholar